BQ-123

未知生产厂商

BQ-123 has been investigated for the basic science and treatment of Coronary Artery Disease, Aorto-coronary Bypass Grafting, and ST-Elevation Myocardial Infarction.

生成 AI 研报

医学正文保留数据源原文，避免将未经专业审核的机器翻译呈现为临床事实。

概览

BQ-123 has been investigated for the basic science and treatment of Coronary Artery Disease, Aorto-coronary Bypass Grafting, and ST-Elevation Myocardial Infarction.

技术标识符

化学式: C₃₁H₄₂N₆O₇
CAS 编号: 136553-81-6
UNII ID: S2A8YZM151

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Intratracheal administration of endothelin-suppressing agents for the treatment of respiratory disorders
US 2009012012 A1申请人: CANTOR JEROME优先权: 2007
US
Therapy for complications of diabetes
EP 2545920 A1申请人: ABBOTT GMBH & CO KG优先权: 2008
EP
Application of endothelin-1A receptor antagonist
CN 114668831 A申请人: UNIV NANTONG优先权: 2022
CN
Endothelin A receptor antagonist-albumin fusion protein and application thereof in prevention and treatment of hypotension in anesthesia induction period
CN 122277757 A申请人: THE FIRST AFFILIATED HOSPITAL CHONGQING MEDICAL AND PHARMACEUTICAL COLLEGE优先权: 2026
CN

药物